
PMC:7781431 / 30047-34443
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
851 | 0-27 | Species | denotes | Respiratory syncytial virus | Tax:12814 |
852 | 29-57 | Species | denotes | human immunodeficiency virus | Tax:12721 |
853 | 63-80 | Disease | denotes | hepatitis C virus | MESH:D006526 |
877 | 736-741 | Gene | denotes | COX-2 | Gene:5743 |
878 | 1085-1089 | Gene | denotes | FPR2 | Gene:2358 |
879 | 1090-1093 | Gene | denotes | ALX | Gene:84941 |
880 | 1098-1103 | Gene | denotes | GPR32 | Gene:2854 |
881 | 81-108 | Species | denotes | Respiratory syncytial virus | Tax:12814 |
882 | 130-135 | Species | denotes | human | Tax:9606 |
883 | 167-171 | Species | denotes | HRSV | Tax:11250 |
884 | 177-199 | Species | denotes | human orthopneumovirus | Tax:11250 |
885 | 136-147 | Species | denotes | respiratory | Tax:12814 |
886 | 1014-1025 | Species | denotes | respiratory | Tax:12814 |
887 | 110-113 | Species | denotes | RSV | Tax:12814 |
888 | 465-468 | Species | denotes | RSV | Tax:12814 |
889 | 724-727 | Species | denotes | RSV | Tax:12814 |
890 | 1042-1045 | Species | denotes | RSV | Tax:12814 |
891 | 1230-1233 | Species | denotes | RSV | Tax:12814 |
892 | 948-979 | Chemical | denotes | polyinosinic-polycytidylic acid | MESH:D011070 |
893 | 1177-1182 | Chemical | denotes | lipid | MESH:D008055 |
894 | 224-246 | Disease | denotes | respiratory infections | MESH:D012141 |
895 | 256-264 | Disease | denotes | infected | MESH:D007239 |
896 | 368-396 | Disease | denotes | respiratory tract infections | MESH:D012141 |
897 | 469-478 | Disease | denotes | infection | MESH:D007239 |
898 | 490-503 | Disease | denotes | bronchiolitis | MESH:D001988 |
899 | 1267-1276 | Disease | denotes | infection | MESH:D007239 |
910 | 1288-1316 | Species | denotes | Human immunodeficiency virus | Tax:12721 |
911 | 1452-1457 | Species | denotes | HIV-1 | Tax:11676 |
912 | 1462-1467 | Species | denotes | HIV-2 | Tax:11709 |
913 | 1318-1321 | Species | denotes | HIV | Tax:12721 |
914 | 1469-1482 | Disease | denotes | HIV infection | MESH:D015658 |
915 | 1508-1533 | Disease | denotes | immunodeficiency syndrome | MESH:D007153 |
916 | 1535-1539 | Disease | denotes | AIDS | MESH:D000163 |
917 | 1597-1601 | Disease | denotes | AIDS | MESH:D000163 |
918 | 1626-1650 | Disease | denotes | opportunistic infections | MESH:D009894 |
919 | 1676-1682 | Disease | denotes | cancer | MESH:D009369 |
935 | 1889-1894 | Gene | denotes | TNF-α | Gene:7124 |
936 | 1900-1914 | Gene | denotes | interleukin-1β | Gene:3553 |
937 | 2308-2313 | Gene | denotes | gp120 | Gene:3700 |
938 | 2348-2352 | Gene | denotes | FPR2 | Gene:2358 |
939 | 2353-2356 | Gene | denotes | ALX | Gene:84941 |
940 | 2425-2429 | Gene | denotes | CCR5 | Gene:1234 |
941 | 2434-2439 | Gene | denotes | CXCR4 | Gene:7852 |
942 | 1791-1796 | Species | denotes | human | Tax:9606 |
943 | 1841-1846 | Species | denotes | human | Tax:9606 |
944 | 2272-2307 | Species | denotes | human immunodeficiency virus type 1 | Tax:11676 |
945 | 1754-1768 | Disease | denotes | HIV-1 infected | MESH:D015658 |
946 | 1810-1821 | Disease | denotes | astrocytoma | MESH:D001254 |
947 | 1859-1874 | Disease | denotes | tumour necrosis | MESH:D009336 |
948 | 2147-2162 | Disease | denotes | viral infection | MESH:D001102 |
949 | 2197-2206 | Disease | denotes | infection | MESH:D007239 |
969 | 2473-2477 | Gene | denotes | FPR2 | Gene:2358 |
970 | 2478-2481 | Gene | denotes | ALX | Gene:84941 |
971 | 2630-2634 | Gene | denotes | CCR3 | Gene:1232 |
972 | 2639-2643 | Gene | denotes | FPR2 | Gene:2358 |
973 | 2644-2647 | Gene | denotes | ALX | Gene:84941 |
974 | 2723-2726 | Gene | denotes | Env | Gene:100616444 |
975 | 2779-2783 | Gene | denotes | FPR2 | Gene:2358 |
976 | 2806-2810 | Gene | denotes | CCR3 | Gene:1232 |
977 | 2835-2842 | Gene | denotes | ChemR23 | Gene:1240 |
978 | 2967-2974 | Gene | denotes | ChemR23 | Gene:1240 |
979 | 3111-3115 | Gene | denotes | FPR2 | Gene:2358 |
980 | 3120-3127 | Gene | denotes | ChemR23 | Gene:1240 |
981 | 2885-2890 | Species | denotes | HIV-1 | Tax:11676 |
982 | 2895-2900 | Species | denotes | HIV-2 | Tax:11709 |
983 | 2544-2547 | Species | denotes | HIV | Tax:12721 |
984 | 2662-2665 | Species | denotes | HIV | Tax:12721 |
985 | 2866-2869 | Species | denotes | HIV | Tax:12721 |
986 | 2982-2991 | Disease | denotes | infection | MESH:D007239 |
987 | 3131-3144 | Disease | denotes | HIV infection | MESH:D015658 |
1018 | 3860-3865 | Gene | denotes | GPR37 | Gene:2861 |
1019 | 3987-3992 | Gene | denotes | GPR37 | Gene:2861 |
1020 | 4166-4170 | Gene | denotes | FPR2 | Gene:2358 |
1021 | 4171-4174 | Gene | denotes | ALX | Gene:84941 |
1022 | 4320-4323 | Gene | denotes | SAA | Gene:6287 |
1023 | 3587-3590 | Gene | denotes | C5A | Gene:728 |
1024 | 4371-4374 | Gene | denotes | SAA | Gene:6287 |
1025 | 4073-4076 | Gene | denotes | SAA | Gene:6287 |
1026 | 3146-3163 | Species | denotes | Hepatitis C virus | Tax:11103 |
1027 | 3434-3440 | Species | denotes | humans | Tax:9606 |
1028 | 3471-3476 | Species | denotes | Lemon | Tax:2708 |
1029 | 3684-3689 | Species | denotes | human | Tax:9606 |
1030 | 3165-3168 | Species | denotes | HCV | Tax:11103 |
1031 | 3304-3307 | Species | denotes | HCV | Tax:11103 |
1032 | 3560-3563 | Species | denotes | HCV | Tax:11103 |
1033 | 3574-3577 | Species | denotes | HCV | Tax:11103 |
1034 | 3627-3630 | Species | denotes | HCV | Tax:11103 |
1035 | 3806-3809 | Species | denotes | HCV | Tax:11103 |
1036 | 3841-3844 | Species | denotes | HCV | Tax:11103 |
1037 | 4059-4062 | Species | denotes | HCV | Tax:11103 |
1038 | 4112-4115 | Species | denotes | HCV | Tax:11103 |
1039 | 3811-3820 | Chemical | denotes | Vitamin D | MESH:D014807 |
1040 | 3345-3352 | Disease | denotes | cancers | MESH:D009369 |
1041 | 3361-3373 | Disease | denotes | liver cancer | MESH:D006528 |
1042 | 3375-3399 | Disease | denotes | hepatocellular carcinoma | MESH:D006528 |
1043 | 3422-3430 | Disease | denotes | lymphoma | MESH:D008223 |
1044 | 4145-4157 | Disease | denotes | inflammation | MESH:D007249 |
1045 | 4184-4196 | Disease | denotes | liver damage | MESH:D056486 |
1046 | 4348-4360 | Disease | denotes | liver damage | MESH:D056486 |
1047 | 4382-4395 | Disease | denotes | HCV infection | MESH:D006526 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T25 | 35-51 | Phenotype | denotes | immunodeficiency | http://purl.obolibrary.org/obo/HP_0002721 |
T26 | 63-72 | Phenotype | denotes | hepatitis | http://purl.obolibrary.org/obo/HP_0012115 |
T27 | 224-246 | Phenotype | denotes | respiratory infections | http://purl.obolibrary.org/obo/HP_0011947 |
T28 | 362-396 | Phenotype | denotes | lower respiratory tract infections | http://purl.obolibrary.org/obo/HP_0002783 |
T29 | 490-503 | Phenotype | denotes | bronchiolitis | http://purl.obolibrary.org/obo/HP_0011950 |
T30 | 1294-1310 | Phenotype | denotes | immunodeficiency | http://purl.obolibrary.org/obo/HP_0002721 |
T31 | 1508-1524 | Phenotype | denotes | immunodeficiency | http://purl.obolibrary.org/obo/HP_0002721 |
T32 | 1626-1650 | Phenotype | denotes | opportunistic infections | http://purl.obolibrary.org/obo/HP_0031690 |
T33 | 1676-1682 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
T34 | 1810-1821 | Phenotype | denotes | astrocytoma | http://purl.obolibrary.org/obo/HP_0009592 |
T35 | 1859-1865 | Phenotype | denotes | tumour | http://purl.obolibrary.org/obo/HP_0002664 |
T36 | 2278-2294 | Phenotype | denotes | immunodeficiency | http://purl.obolibrary.org/obo/HP_0002721 |
T37 | 3146-3155 | Phenotype | denotes | Hepatitis | http://purl.obolibrary.org/obo/HP_0012115 |
T38 | 3324-3333 | Phenotype | denotes | hepatitis | http://purl.obolibrary.org/obo/HP_0012115 |
T39 | 3361-3373 | Phenotype | denotes | liver cancer | http://purl.obolibrary.org/obo/HP_0002896 |
T40 | 3375-3399 | Phenotype | denotes | hepatocellular carcinoma | http://purl.obolibrary.org/obo/HP_0001402 |
T41 | 3422-3430 | Phenotype | denotes | lymphoma | http://purl.obolibrary.org/obo/HP_0002665 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T299 | 0-80 | Sentence | denotes | Respiratory syncytial virus, human immunodeficiency virus, and hepatitis C virus |
T300 | 81-334 | Sentence | denotes | Respiratory syncytial virus (RSV), also known as human respiratory cell fusion virus (HRSV) and human orthopneumovirus, is a virus that causes respiratory infections in which infected mucosal cells fuse to form a syncytium (Schweitzer and Justice 2020). |
T301 | 335-464 | Sentence | denotes | It is the leading cause of lower respiratory tract infections and hospital visits in infancy and childhood (Read and Bosco 2020). |
T302 | 465-635 | Sentence | denotes | RSV infection results in bronchiolitis, which is classically caused by activated macrophages and eventually resolved by alternatively activated macrophages (Shirey et al. |
T303 | 636-642 | Sentence | denotes | 2010). |
T304 | 643-816 | Sentence | denotes | The promotion of these two alternative macrophage fates appears to be related to RSV-induced COX-2 and LXA4 and RvE1-mediated protective measures (Fig. 4) (Richardson et al. |
T305 | 817-836 | Sentence | denotes | 2005; Shirey et al. |
T306 | 837-843 | Sentence | denotes | 2014). |
T307 | 844-1117 | Sentence | denotes | Also, although it does not directly act on the virus, RvD1 inhibits inflammatory signal transduction by polyinosinic-polycytidylic acid, an analogue of RNAs derived from respiratory viruses such as RSV, and the action of RvD1 is mediated by FPR2/ALX and GPR32 (Hsiao et al. |
T308 | 1118-1124 | Sentence | denotes | 2014). |
T309 | 1125-1287 | Sentence | denotes | These reports suggest the critical role of SPMs and lipid mediator class shift in the host’s response to RSV in the initial control and final infection clearance. |
T310 | 1288-1468 | Sentence | denotes | Human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retroviruses) and are classified into two based on the genetic characteristics and viral antigen, HIV-1 and HIV-2. |
T311 | 1469-1585 | Sentence | denotes | HIV infection may progress to acquired immunodeficiency syndrome (AIDS), a progressive failure of the immune system. |
T312 | 1586-1704 | Sentence | denotes | Over time, AIDS causes life-threatening opportunistic infections and a condition in which cancer thrives (Douek et al. |
T313 | 1705-1724 | Sentence | denotes | 2009; Powell et al. |
T314 | 1725-1731 | Sentence | denotes | 2016). |
T315 | 1732-2045 | Sentence | denotes | When co-cultured with HIV-1 infected mononuclear cells and human glial cells (astrocytoma, glial and primary human astrocyte), tumour necrosis factor alpha (TNF-α) and interleukin-1β are produced, and large amounts of LTB4, LTD4, LXA4, and PAF, were also found in media from this co-culture (Fig. 4) (Genis et al. |
T316 | 2046-2052 | Sentence | denotes | 1992). |
T317 | 2053-2163 | Sentence | denotes | So far, this is the only in vitro study to prove, that LXs are produced in direct response to viral infection. |
T318 | 2164-2239 | Sentence | denotes | However, the role of LXs in this infection model has not been investigated. |
T319 | 2240-2465 | Sentence | denotes | Synthetic peptides derived from human immunodeficiency virus type 1 gp120 activate the 7-transmembrane GPCR FPR2/ALX, down-regulating the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes (Deng et al. |
T320 | 2466-2472 | Sentence | denotes | 1999). |
T321 | 2473-2563 | Sentence | denotes | FPR2/ALX acts as an efficient core receptor for the primary isolate of HIV (Shimizu et al. |
T322 | 2564-2570 | Sentence | denotes | 2008). |
T323 | 2571-2681 | Sentence | denotes | Viral entries through the alternative core receptors (CoR) CCR3 and FPR2/ALX depend on the HIV type 1 subtype. |
T324 | 2682-2827 | Sentence | denotes | Viruses pseudotyped with subtype A and C Env proteins use the recently described alternative CoR FPR2 more efficiently than CCR3 (Nedellec et al. |
T325 | 2828-2834 | Sentence | denotes | 2009). |
T326 | 2835-2870 | Sentence | denotes | ChemR23 also acts as a CoR for HIV. |
T327 | 2871-3010 | Sentence | denotes | At this time, HIV-1 and HIV-2 appear to use the N-terminus and the second extracellular loop of ChemR23 during infection (Martensson et al. |
T328 | 3011-3017 | Sentence | denotes | 2006). |
T329 | 3018-3145 | Sentence | denotes | As mentioned above, research is needed to determine the role of SPMs that act as ligands for FPR2 and ChemR23 in HIV infection. |
T330 | 3146-3292 | Sentence | denotes | Hepatitis C virus (HCV) is a positive-sense single-stranded RNA virus of the family Flaviviridae with a small (55–65 nm size) envelope (Lee et al. |
T331 | 3293-3299 | Sentence | denotes | 2017). |
T332 | 3300-3454 | Sentence | denotes | The HCV is the cause of hepatitis C and some cancers such as liver cancer (hepatocellular carcinoma, abbreviated HCC) and lymphoma in humans (Ferri et al. |
T333 | 3455-3483 | Sentence | denotes | 2015; Rusyn and Lemon 2014). |
T334 | 3484-3564 | Sentence | denotes | To date, there appears to be no report on the effectiveness of SPMs against HCV. |
T335 | 3565-3712 | Sentence | denotes | However, HCV peptide (C5A), an amphiphilic α-helix peptide of HCV, is an activator of the N-formyl peptide receptor in human phagocytes (Lin et al. |
T336 | 3713-3719 | Sentence | denotes | 2011). |
T337 | 3720-3810 | Sentence | denotes | This suggests the possibility of interaction between RvD1 and LXA4, FPR families, and HCV. |
T338 | 3811-3933 | Sentence | denotes | Vitamin D metabolites inhibit HCV and upregulate GPR37 gene expression, which induces cellular autophagy (Gutierrez et al. |
T339 | 3934-3940 | Sentence | denotes | 2014). |
T340 | 3941-4072 | Sentence | denotes | PD1 was recently proposed as a new ligand for GPR37, and some studies suggest a possible relationship between PD1 and HCV (Fig. 4). |
T341 | 4073-4223 | Sentence | denotes | SAA also has antiviral effects against HCV, however, it induces chronic inflammation through FPR2/ALX, causing liver damage (Abouelasrar Salama et al. |
T342 | 4224-4230 | Sentence | denotes | 2019). |
T343 | 4231-4396 | Sentence | denotes | Although research has not been conducted yet, RvD1 and LXA4, which inhibit the action of SAA, are likely to suppress liver damage caused by SAA during HCV infection. |